• EI
  • Scopus
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
  • DOAJ
  • EBSCO
  • 北大核心期刊
  • 中国核心学术期刊RCCSE
  • JST China
  • FSTA
  • 中国精品科技期刊
  • 中国农业核心期刊
  • CA
  • WJCI
  • 中国科技核心期刊CSTPCD
  • 中国生物医学SinoMed
中国精品科技期刊2020
赵琳,姜雨,兰韬,等. 硫酸软骨素钠质量安全标准及关键控制点研究进展[J]. 食品工业科技,2022,43(19):7−13. doi: 10.13386/j.issn1002-0306.2022030218.
引用本文: 赵琳,姜雨,兰韬,等. 硫酸软骨素钠质量安全标准及关键控制点研究进展[J]. 食品工业科技,2022,43(19):7−13. doi: 10.13386/j.issn1002-0306.2022030218.
ZHAO Lin, JIANG Yu, LAN Tao, et al. Review on Quality Safety Standards and Critical Control Points of Chondroitin Sulfate Sodium[J]. Science and Technology of Food Industry, 2022, 43(19): 7−13. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2022030218.
Citation: ZHAO Lin, JIANG Yu, LAN Tao, et al. Review on Quality Safety Standards and Critical Control Points of Chondroitin Sulfate Sodium[J]. Science and Technology of Food Industry, 2022, 43(19): 7−13. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2022030218.

硫酸软骨素钠质量安全标准及关键控制点研究进展

Review on Quality Safety Standards and Critical Control Points of Chondroitin Sulfate Sodium

  • 摘要: 硫酸软骨素钠是从动物软骨组织中提取的天然酸性黏多糖,主要作为一种抗骨关节炎药品和保健食品在世界范围内被广泛应用。由于硫酸软骨素钠的结构、物理化学特征、生理活性会因动物种类、组织、提取工艺的不同而存在差异,使得硫酸软骨素钠的质量安全控制存在难度。国内外针对硫酸软骨素钠都制定有相应标准,本文以中国、美国、日本、欧洲药典收载的硫酸软骨素钠原料标准为依据,进行分析、归纳和总结,综述了硫酸软骨素钠质量安全标准化发展现状和趋势。结合最新的研究成果,进一步提炼影响硫酸软骨素钠质量安全的关键控制点,对来源、潜在外源污染物、掺假等因素进行深入分析与探讨,有助于监管部门、生产企业准确把握影响硫酸软骨素钠质量安全的风险源。本文也明确了未来硫酸软骨素钠质量安全标准化的工作需求,为硫酸软骨素钠质量安全标准体系的不断完善提供参考。

     

    Abstract: Chondroitin sulfate sodium is an acidic mucopolysaccharide extracted from animal cartilage, and has been widely used in the world as anti-osteoarthritis and health food. It is difficult to control the quality and safety of chondroitin sulfate sodium, due to the structure, physical and chemical characteristics, physiological activities of chondroitin sulfate sodium vary with the different animal species, tissues and extraction processes. There are corresponding standards for chondroitin sulfate sodium at home and abroad. Based on the raw material standards of chondroitin sulfate sodium collected in the pharmacopoeia of China, the United States, Japan and Europe, this paper analyzes and summarizes the development status and trend of quality and safety standardization of chondroitin sulfate sodium. Combined with the latest research results, the critical control points affecting the quality and safety of chondroitin sulfate sodium are further extracted, and the sources, potential exogenous pollutants and adulteration are deeply analyzed and discussed, which is conducive to accurately grasp the risk sources affecting the quality and safety of chondroitin sulfate sodium for the supervision department and production enterprises. This paper clarifies the future requirements of quality and safety standardization of chondroitin sulfate sodium, providing reference for the continuous improvement of quality and safety standard system of chondroitin sulfate sodium.

     

/

返回文章
返回